Fundz

Celegence Acquires Qdossier To Bolster Its Regulatory Consultancy Services And Solutions For The Pharmaceutical Industry

PRIVATEJul 18, 2022

Acquiring Company

Celegence

Acquired Company

Qdossier

SoftwareMedia And EntertainmentManufacturingSoftware

Description

Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Qdossier also provides leading cloud-based technology, which creates transparency, consistency, and reusability across regulatory dossiers.

Quick answer

Celegence is acquiring Qdossier, announced July 18, 2022.

How much did Celegence pay for Qdossier?
The deal value was not disclosed.
What does Celegence do?
Celegence helps life sciences companies navigate complex global regulatory requirements by providing consulting services and solutions dedicated to regulatory affairs.

Source: Fundz verified event record.

Other recent acquisitions in Media And Entertainment and Software

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Celegence, and when

When Celegence changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Celegence raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Celegence, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Celegence. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Celegence

About

Celegence helps life sciences companies navigate complex global regulatory requirements by providing consulting services and solutions dedicated to regulatory affairs. Celegence supports life science customers in the areas of EU MDR compliance, IVDR compliance, regulatory intelligence, RIMS data management, publishing, regulatory labeling including UDI consulting, and medical writing. Celegence's depth of experience and extensive delivery capabilities allow regulatory affairs and quality teams to operate more efficiently, reduce cost, and improve compliance. For more information, visit www.celegence.com or follow Celegence on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Celegence makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Celegence's next move

Learn about Strategic plan

Frequently asked

Who acquired Qdossier?

Qdossier was acquired by Celegence. The deal was reported on July 18, 2022. Celegence helps life sciences companies navigate complex global regulatory requirements by providing consulting services and solutions dedicated to regulatory affairs. Celegence is privately held and operates in Software.

When did Celegence acquire Qdossier?

Celegence's acquisition of Qdossier was reported on July 18, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Qdossier do?

Qdossier helps life sciences organizations record and exchange proof of quality, safety, and efficacy of medicinal products. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.